Anne Linda Van Kappel, Françloise Clavel-Chapelon, Jean-Paul Steghens, Kim Overvad, Nadia Slimani, Petra H.M. Peeters, Sheila Bingham, H. Bas Bueno-de-Mesquita, Catherine Guibout, Vassiliki Benetou, Ingegerd Johansson, Ailsa A Welch, José Ramón Quirós, Anne Tjønneland, Antonia Trichopoulou, Heiner Boeing, Egidio Celentano, Domenico Palli, Rudolf Kaaks, Wael K. Al-Delaimy, Carmen Navarro, Peter Wallström, Jakob Linseisen, Pietro Ferrari, Timothy J. Key, Elio Riboli, Unit of Nutrition and Cancer, International Agency for Cancer Research (IACR), Unit of Nutrition, Environment, and Cancer, Catalan Institute of Oncology, Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut de Chimie du CNRS (INC)-École Supérieure Chimie Physique Électronique de Lyon-Centre National de la Recherche Scientifique (CNRS), Nutrition Unit, MRC Dunn Human, Laboratory of Plant Physiology and Biophysics, IBLS Plant Sciences, University of Glasgow, Department of Plant Biochemistry, Lund University [Lund], Department of Cardiology and Department of Clinical Epidemiology, Aarhus University Hospital, Department of Clinical Epidemiology, Institute og Cancer Epidemiology, Danish Cancer Society, Institute of Cancer Epidemiology, Radcliffe Infirmary, Cancer Research UK, Cancer Research UK Epidemiology Unit, University of Oxford [Oxford], National Institute for Public Health and the Environment [Bilthoven] (RIVM), Center for Nutrition and Health, National Institute of Public Health and Environment, Julius Centre for Health Sciences and Primary Care, VU University Medical Center [Amsterdam], Julius Center for Health Sciences and Primary Care, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DifE), Leibniz Association, Division of Clinical Epidemiology, Deutches Krebsforschungszentrum, Nutrition, hormones et cancer: épidémiologie et prévention (E3N), Epidémiologie, sciences sociales, santé publique (IFR 69), Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11), Epidémiologie des cancers, Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie des cancers : Radiocarcinogénèse et effets iatrogènes des traitements, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Departamento de Biología Animal, Universidad de Extremadura (UEX)-Departamento de Biología Animal, Institut de Biologie du Développement de Marseille (IBDM), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Epidemiology Department, Health Council of Murcia, Public Health and Health Planning Directorate, Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Center, University of Athens Medical School [Athens], Department of Hygiene and Epidemiology, Unit of nutritional cancer, IARC-WHO, Nutrition and Hormone Group, Guibout, Catherine, Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-École Supérieure Chimie Physique Électronique de Lyon-Centre National de la Recherche Scientifique (CNRS), Aalborg Hospital-Aarhus University Hospital, Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU)-Collège de France (CdF)-Centre National de la Recherche Scientifique (CNRS), University of Athens Medical School, Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), University of Oxford, Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Universidad de Extremadura - University of Extremadura (UEX)-Departamento de Biología Animal
Background:In addition to their possible direct biological effects, plasma carotenoids can be used as biochemical markers of fruit and vegetable consumption for identifying diet–disease associations in epidemiological studies. Few studies have compared levels of these carotenoids between countries in Europe.Objective:Our aim was to assess the variability of plasma carotenoid levels within the cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).Methods:Plasma levels of six carotenoids – α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein and zeaxanthin – were measured cross-sectionally in 3043 study subjects from 16 regions in nine European countries. We investigated the relative influence of gender, season, age, body mass index (BMI), alcohol intake and smoking status on plasma levels of the carotenoids.Results:Mean plasma level of the sum of the six carotenoids varied twofold between regions (1.35μmoll−1for men in Malmö, Sweden vs. 2.79μmoll−1for men in Ragusa/Naples, Italy; 1.61μmoll−1for women in The Netherlands vs. 3.52μmoll−1in Ragusa/Naples, Italy). Mean levels of individual carotenoids varied up to fourfold (α-carotene: 0.06μmoll−1for men in Murcia, Spain vs. 0.25μmoll−1for vegetarian men living in the UK). In multivariate regression analyses, region was the most important predictor of total plasma carotenoid level (partialR2=27.3%), followed by BMI (partialR2=5.2%), gender (partialR2=2.7%) and smoking status (partialR2=2.8%). Females had higher total carotenoid levels than males across Europe.Conclusions:Plasma levels of carotenoids vary substantially between 16 different regions in Italy, Greece, Spain, France, Germany, the UK, Sweden, Denmark and The Netherlands. Compared with region of residence, the other demographic and lifestyle factors and laboratory measurements have limited predictive value for plasma carotenoid levels in Europe.